Study on the distribution of ABO blood group in patients with pancreatic cancer

• Published in: Zhongguo shu xue za zhi Vol. 36; no. 2; pp. 152 - 155
• Main Authors: Xiaoliang YANG, Xiaoqin ZHOU, Jing LI, Xia ZHONG, Kun WANG, Xiaoyan TANG, Xing GU
• Format: Journal Article
• Language: Chinese
• Published: Institute of Blood Transfusion of Chinese Academy of Medical Sciences 01.02.2023
• Subjects: blood group distribution; digestive tract neoplasms; pancreatic cancer
• ISSN: 1004-549X
• DOI: 10.13303/j.cjbt.issn.1004-549x.2023.02.014

Objective To investigate whether there is a correlation between the differences in ABO blood group distribution in patients with pancreatic cancer, and to evaluate the relative risk. Methods Patients with pathological diagnosis or discharge diagnosis of pancreatic cancer who underwent ABO blood group typing in our hospital from January 2017 to October 2021 were selected, and the blood group distribution of patients and the correlation were analyzed. Results There was a statistically significant difference between the pancreatic cancer group and the control group (P<0.05). The study showed that type A may be a relative risk factor for pancreatic cancer patients (χ2=42.44, P<0.001), and type B may play a protective role (χ2=16.28, P<0.01). Significant differences were found in distribution between different gender groups (χ2=64.35, P<0.05). The test results showed that type A may be a risk factor for pancreatic cancer in men (χ2=35.2, OR=1.7, 95%CI=0.59-1.02, P<0.001), and type O may play a protective role in p